ProCE Banner Activity

How I Use Resistance Testing to Guide Management of Patients With Chronic Hepatitis C

Clinical Thought
Using a recent case patient, I outline my current approach to using HCV resistance testing to select therapy in patients who have previously received an HCV NS5A inhibitor.

Released: September 15, 2015

Expiration: September 13, 2016

Share

Faculty

Mark S. Sulkowski

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Janssen

Faculty Disclosure

Primary Author

Mark S. Sulkowski, MD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, has disclosed that he has received consulting fees from AbbVie, Achillion, Bristol‐Myers Squibb, Gilead Sciences, Janssen, and Merck; and funds for research support from AbbVie, Bristol‐Myers Squibb, Gilead Sciences, Janssen, and Merck.